This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Merck KGAA has agreed to acquire Geneva-based biotech Serono SA in a deal valued at CHF16.6bn ($12.9bn). Merck will initially buy out majority shareholders the Bertarelli family, which accounts for a 64.5% stake in Serono; the company plans to continue with a public tender offer in 2007 to acquire the remaining shares.
Payment Includes Cash
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?